Healthy Extracts' Gummy USA Secures 6 Million Gummy Follow-On Order from Woman's Health Nutraceutical Leader
Healthy Extracts (OTCQB: HYEX) announced that its Gummy USA subsidiary received a 6 million gummy follow-on order for a proprietary women's formulation, scheduled to ship within four weeks. The gummies target hormonal-balance symptoms such as missed periods, acne, excess hair growth, infertility and weight gain and were developed with client medical advisors. Gummy USA cites selection over competitors for superior texture and flavor with challenging ingredients and says its HACCP, GMP-certified, FDA-registered facility is scaling to meet rising private-label demand. The company references a recent merger integrating R&D, manufacturing, distribution and sales.
Healthy Extracts (OTCQB: HYEX) ha annunciato che la sua controllata Gummy USA ha ricevuto un ordine di riordino di 6 milioni di gommini per una formulazione proprietaria femminile, previsto per la spedizione entro quattro settimane. Le gommini mirano ai sintomi di equilibrio ormonale come mestruazioni saltate, acne, crescita eccessiva dei peli, infertilità e aumento di peso e sono state sviluppate con i consulenti medici del cliente. Gummy USA cita la preferenza rispetto ai concorrenti per una texture e un sapore superiori nonostante ingredienti sfidanti e afferma che la sua struttura HACCP, certificata GMP, registrata FDA è in espansione per soddisfare la crescente domanda di marchi privati. L'azienda fa riferimento a una recente fusione che integra Ricerca e Sviluppo, produzione, distribuzione e vendita.
Healthy Extracts (OTCQB: HYEX) anunció que su subsidiaria Gummy USA recibió un pedido de seguimiento de 6 millones de gomitas para una formulación propietaria para mujeres, programado para enviarse dentro de cuatro semanas. Las gomitas apuntan a síntomas de equilibrio hormonal como periodos ausentes, acné, exceso de vello, infertilidad y aumento de peso y fueron desarrolladas con asesores médicos del cliente. Gummy USA cita la preferencia sobre los competidores por su textura y sabor superiores pese a ingredientes desafiantes y afirma que su instalación HACCP, certificada GMP, registrada por la FDA está ampliándose para satisfacer la creciente demanda de marcas privadas. La empresa menciona una fusión reciente que integra I+D, fabricación, distribución y ventas.
Healthy Extracts (OTCQB: HYEX)가 자회사 Gummy USA가 독자적인 여성용 포뮬레이션을 위한 600만 개의 구미 후속 주문을 받았다고 발표했으며, 4주 안에 선적될 예정입니다. 이 구미는 월경 주기 균형과 관련된 증상들(생리 불순, 여드름, 과다 모발 증가, 불임 및 체중 증가)을 겨냥하며 고객의 의료 자문과 함께 개발되었습니다. Gummy USA는 까다로운 성분에도 불구하고 질감과 맛이 우수하다고 경쟁사 대비 선택되었다고 밝히며, HACCP, GMP 인증, FDA 등록 시설이 증가하는 프라이빗 라벨 수요를 충족하기 위해 확장 중이라고 말합니다. 이 회사는 연구개발, 제조, 유통 및 판매를 통합하는 최근의 합병을 언급합니다.
Healthy Extracts (OTCQB: HYEX) a annoncé que sa filiale Gummy USA a reçu un ordre de rappel de 6 millions de gommes pour une formulation exclusive féminine, prévu pour être expédié dans quatre semaines. Les gommes ciblent les symptômes d'équilibre hormonal tels que les règles absentes, l'acné, la croissance excessive des poils, l'infertilité et la prise de poids et ont été développées avec les conseillers médicaux du client. Gummy USA affirme être préféré aux concurrents pour une texture et une saveur supérieures malgré des ingrédients exigeants et indique que son établissement HACCP, certifié GMP, enregistré FDA est en expansion pour répondre à la croissance de la demande en marque blanche. L'entreprise fait référence à une fusion récente intégrant la R&D, la fabrication, la distribution et les ventes.
Healthy Extracts (OTCQB: HYEX) gab bekannt, dass seine Tochtergesellschaft Gummy USA eine Nachfolgebestellung über 6 Millionen Gummis für eine firmeneigene Frauenformulierung erhalten hat, die voraussichtlich innerhalb von vier Wochen versendet wird. Die Gummis zielen auf hormonell bedingte Balance-Symptome wie ausbleibende Perioden, Akne, übermäßiges Haarwachstum, Unfruchtbarkeit und Gewichtszunahme ab und wurden mit medizinischen Beratern des Kunden entwickelt. Gummy USA führt sich gegenüber Wettbewerbern durch eine bessere Textur und Geschmack bei herausfordernden Zutaten und sagt, dass seine HACCP-, GMP-zertifiziert, FDA-registriert Anlage bereit ist, der steigenden Nachfrage nach Private-Label-Produkten gerecht zu werden. Das Unternehmen verweist auf eine jüngste Fusion, die F&E, Herstellung, Vertrieb und Vertrieb integriert.
Healthy Extracts (OTCQB: HYEX) أعلنت أن شركتها التابعة Gummy USA قد تلقت طلب متابعة لستة ملايين حبة جومي لصيغة نسائية حصرية، ومن المقرر شحنها خلال أربعة أسابيع. تستهدف الحبوب أعراض توازن هرموني مثل غياب الطمث، حب الشباب، نمو الشعر الزائد، العقم وزيادة الوزن، وتم تطويرها مع مستشاري الطب لدى العميل. تشير Gummy USA إلى تفوقها على المنافسين من حيث القوام والنكهة بالرغم من المكونات الصعبة وتقول أن منشأتها HACCP، معتمدة GMP، ومسجلة FDA قيد التوسع لتلبية الطلب المتزايد على العلامة الخاصة. وتشير الشركة إلى اندماج حديث يدمج البحث والتطوير والتصنيع والتوزيع والمبيعات.
Healthy Extracts (OTCQB: HYEX) 宣布其 Gummy USA 子公司获得了一个 600万颗糖胶后续订单，用于一种专有的女性配方，预计在 四周内发货。该糖胶针对荷尔蒙平衡相关症状，如月经缺失、痤疮、多余毛发生长、不孕和体重增加，且与客户的医疗顾问共同开发。Gummy USA 指出相较竞争对手在质地和口味方面更优，尽管成分具有挑战性，并表示其 HACCP、GMP认证、FDA注册的设施正在扩产以满足日益增长的私有标签需求。公司提及最近的合并，将研发、制造、分销和销售整合在一起。
- 6 million-unit follow-on private-label order
- Order scheduled to ship within four weeks
- HACCP, GMP-certified, FDA-registered manufacturing facility
- Merger provided vertical integration of R&D, manufacturing and distribution
- None.
Major private-label win awarded by leading direct-to-consumer and top Amazon seller of high-quality natural nutritional supplements for women.
Specially formulated gummies designed to naturally support a woman's hormonal balance and overall health and well-being.
Gummy USA chosen among multiple competitors based on unique formulation and technology that delivers superior gummy texture and flavor-even with the most challenging ingredients.
Large follow-on order scheduled to ship within four weeks, keeping Healthy Extracts on track for another year of record revenue growth and profitability.
LAS VEGAS, NV / ACCESS Newswire / October 23, 2025 / Healthy Extracts™ Inc. (OTCQB:HYEX), an industry leader in the acquisition, development, manufacturing and marketing of science-based nutraceuticals and oral delivery systems, announced that its new Gummy USA™ subsidiary has received a 6 million gummy follow-on order featuring a proprietary Gummy USA formulation for women.
Created in collaboration with Gummy USA's R&D team, the specially formulated gummies are designed to help support a woman's hormonal balance and overall health and well-being.
It is formulated for women experiencing missed or irregular menstrual periods, excess hair growth, acne, infertility, and weight gain. The flavorful gummy enables easy and enjoyable consumption anytime, anywhere.
The gummy was formulated under the guidance of the client's team of top-rated doctors, clinical professors and healthcare professionals, including board-certified internists, best-selling authors and leaders in family medicine.
"Creating an effective supplement designed for women's hormonal needs can be especially challenging," stated Loraine Lawson, director of science for Gummy USA. "This innovative formulation provides a natural solution for helping women better navigate their health and wellbeing."
The large follow-on order marks the further expansion of Gummy USA's private label production pipeline and further validates the company's advanced formulation and manufacturing technology.
"After extensive competitive evaluation, this valued private label client chose Gummy USA due to our ability to produce gummies with superior texture and flavor, even with very challenging ingredients," stated Don Swanson, Gummy USA founder and CEO of Healthy Extracts. "Given the high demand and top reviews this product has received over the recent months, we're excited to quickly process this large follow-on order with more expected to follow."
Gummy USA provides solutions in collaboration with its clients that deliver the highest quality gummies that truly address their unique health and wellness challenges. As demand for functional and condition-specific supplements continues to surge, Gummy USA's HACCP, GMP-certified, and FDA-registered facility is scaling production to meet accelerating commercial orders across multiple categories.
"This fantastic collaboration aligns perfectly with our mission to bring high-quality gummies to the nutritional supplements marketplace," added Swanson. "Our rapid fulfillment of this order demonstrates the advanced capabilities and scalability of our in-house manufacturing platform and keeps us on track for another year of record growth and profitability."
Healthy Extracts' recent merger of Gummy USA continues to transform its business and growth outlook, providing vertical integration of R&D, manufacturing, distribution and sales, while expanding its oral delivery technology portfolio beyond gel packs and functional straws into precision-dosed gummies.
Driven by a growing roster of premium white-label clients, Gummy USA remains on track to meet or exceed its 2025 production targets.
To learn more about Healthy Extracts, visit healthyextractsinc.com
About Healthy Extracts
Healthy Extracts Inc. (OTCQB:HYEX) develops, manufactures and markets proprietary, science-based supplements for brain, heart, and gut health. The platform enables clinically tested formulas and exclusive partnerships that deliver wellness solutions with measurable consumer and shareholder value.
The company's Gummy USA™ subsidiary is a leading developer and manufacturer of precision-dosed nutraceutical and pharmaceutical-grade gummies. Its proprietary patent-pending SureDose™ technology delivers superior safety, efficacy and compliance for white and private label customers.
Healthy Extracts wholly owned subsidiaries, BergametNA™ and Ultimate Brain Nutrients™ (UBN), offer nutraceutical natural heart and brain health supplements. BergametNA products are the only heart health supplements distributed in North America containing Citrus Bergamot SuperFruit™, the only superfruit with the highest known concentration of polyphenols and flavonoids.
The company also has exclusive agreements for other innovative oral delivery systems that include Gelteq gel-packs and the Gut Health Straw, both of which provide superior bioavailability and ultimate consumer convenience.
To learn more, go to: healthyextractsinc.com, bergametna.com, tryubn.com or gummyusa.com.
Forward-Looking Statements and Safe Harbor Notice
All statements other than statements of historical facts included in this press release are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). Such forward-looking statements include our expectations and those statements that use forward-looking words such as "projected," "expect," "possibility" and "anticipate." The achievement or success of the matters covered by such forward-looking statements involve significant risks, uncertainties and assumptions. Actual results could differ materially from current projections or implied results. Investors should read the risk factors set forth in the Company's Annual Report on Form 10-K filed with the SEC on April 1, 2025, and future periodic reports filed with the U.S. Securities and Exchange Commission (SEC). All of the Company's forward-looking statements are expressly qualified by all such risk factors and other cautionary statements. The Company cautions that statements and assumptions made in this news release constitute forward-looking statements and make no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. The information set forth herein speaks only to the date hereof. The Company and its management undertake no obligation to revise these statements following the date of this news release.
Food & Drug Administration Disclosure
The products mentioned in this press release is not for use by or sale to persons under the age of 12. This product should be used only as directed on the label. Consult with a physician before use if you have a serious medical condition or use prescription medications. A doctor's advice should be sought before using this and any supplemental dietary product. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease.
Gummy USA ™, BergametNA™, Ultimate Brain Nutrients™, UBN™, Citrus Bergamot SuperFruit™ and F4T® are trademarks and registered trademarks of Healthy Extracts™ Inc.
Company Contact
Healthy Extracts Inc.
Tel (720) 463-1004
Email contact
Investor Contact
CMA Investor Relations
Tel (949) 432-7554
Email contact
SOURCE: HEALTHY EXTRACTS INC.
View the original press release on ACCESS Newswire
FAQ
What did HYEX announce about the 6 million gummy order on October 23, 2025?
How will the 6 million gummy order affect HYEX production timelines?
What certifications does Gummy USA's facility have for HYEX (HYEX)?
What health issues does the HYEX women's gummy formulation target?
Did HYEX say the new order validates Gummy USA's technology?
Where can investors learn more about Healthy Extracts (HYEX)?
